About
Biotechnology Newsfeed
Choose content
Create your own custom newsfeed
|
Set preferences
Set up your newsfeed details, look and feel and desired output
|
Create account
Enter your registration information
|
-
VSY Biotechnology Enters the Japanese Market!
11 Jul 2025 08:00 GMT
EIN Presswire
… Trifocal Technology® developed by VSY Biotechnology GmbH has been officially approved … have been eliminated with VSY Biotechnology GmbH ’s Sinusoidal Trifocal … Japan, recently visited the VSY Biotechnology GmbH headquarters in Leinfelden-Echterdingen …
-
MAIA Biotechnology enrolls first patient in expansion of phase 2 clinical trial for ateganosine in advanced non─small cell lung cancer
11 Jul 2025 06:35 GMT
Pharmabiz.com
MAIA Biotechnology, Inc, a targeted therapy and …
-
Gewu Biotechnology discovers new EZH1 and/or EZH2 inhibitors
10 Jul 2025 17:47 GMT
BioWorld
Cancer Gewu Biotechnology (Jiangsu) Co. Ltd. has described …
-
MAIA Biotechnology doses first patient in expansion of Phase II lung cancer trial
10 Jul 2025 17:37 GMT
Clinical Trials Arena
US-based MAIA Biotechnology has dosed the first subject … CPI and chemotherapy treatments. MAIA Biotechnology CEO Vlad Vitoc said: “We … approved standard of care.” MAIA Biotechnology noted that as of May …
-
VSY Biotechnology Enters the Japanese Market!
10 Jul 2025 11:03 GMT
Ophthalmology Breaking News
… Technology® developed by VSY Biotechnology has been officially approved in … have been eliminated with VSY Biotechnology’s Sinusoidal Trifocal Technology®. … Japan, recently visited the VSY Biotechnology headquarters in Leinfelden-Echterdingen, Germany …
-
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering
09 Jul 2025 21:15 GMT
GlobeNewswire, Inc.
… registered direct offering for Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT), … the exclusive placement agent. Lixte Biotechnology Holdings, Inc., a clinical- … .com. About Lixte Biotechnology Holdings, Inc. Lixte Biotechnology Holdings, Inc. is …
-
Pharmaceuticals and Biotechnology Asset Purchase Agreement Trends Analysis Report 2025 with Directory of High-Value Pharma Deals & Contract Links - ResearchAndMarkets.com
09 Jul 2025 16:21 GMT
Voice of Alexandria - Minnesota
… Purchase Deals in Pharmaceuticals and Biotechnology provides a detailed understanding … Purchase Deals in Pharmaceuticals and Biotechnology provides the reader with … 416-8900 KEYWORD: INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH SOURCE: Research and …
-
M.Sc. Medical Biotechnology and Bioinformatics
09 Jul 2025 09:51 GMT
IndiaBioscience
… M.Sc. program in Medical Biotechnology and Bioinformatics — a unique opportunity …
- Lawmakers Renew Security Concerns Over GenScript Biotechnology’s Alleged CCP Ties 09 Jul 2025 10:53 GMT The Epoch Times
-
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 Jul 2025 20:01 GMT
GlobeNewswire, Inc.
… . (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of …
-
Rakovina Therapeutics Congratulates Partner - Variational AI for Winning LifeSciencesBC’s 2025 Emerging Biotech Company of the Year Award
11 Jul 2025 13:56 GMT
GlobeNewswire, Inc.
… recognizes a British Columbia-based biotechnology company demonstrating exceptional progress and …
-
Creative Medical Technology Holdings Receives Notice of Allowance for ImmCelz™ for Treatment of Heart Failure and/or Post Infarct Pathological Remodeling
11 Jul 2025 12:01 GMT
GlobeNewswire, Inc.
… the “Company”), a clinical-stage biotechnology company specializing in regenerative medicine … : CELZ) is a clinical-stage biotechnology company pioneering regenerative medicine solutions …
-
Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
10 Jul 2025 20:01 GMT
GlobeNewswire, Inc.
… Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision … , Inc. Cogent Biosciences is a biotechnology company focused on developing precision …
-
PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results
10 Jul 2025 12:00 GMT
GlobeNewswire, Inc.
… , 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech … U.S. About PDS Biotechnology PDS Biotechnology is a late-stage immunotherapy … a registered trademark of PDS Biotechnology Corporation. Investor Contact: Mike Moyer …
-
Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference
10 Jul 2025 12:00 GMT
GlobeNewswire, Inc.
… , Inc. is a clinical-stage biotechnology company discovering and developing novel …
-
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
10 Jul 2025 11:35 GMT
GlobeNewswire, Inc.
… global, fully integrated clinical-stage biotechnology company focused on developing innovative …
-
Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
10 Jul 2025 09:10 GMT
GlobeNewswire, Inc.
… AG is a clinical-stage biotechnology company pioneering the development of …
-
New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials
09 Jul 2025 12:05 GMT
GlobeNewswire, Inc.
… , 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the … this year.” About LIXTE Biotechnology Holdings, Inc. LIXTE Biotechnology Holdings, Inc. is …
-
Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors
09 Jul 2025 12:45 GMT
GlobeNewswire, Inc.
… Intrinsic Medicine, a privately held biotechnology company. He also leads Chuang …
-
Benitec Biopharma Provides Operational Updates
09 Jul 2025 12:00 GMT
GlobeNewswire, Inc.
… clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines … “Company”) is a clinical-stage biotechnology company focused on the advancement …
-
DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors
09 Jul 2025 12:00 GMT
GlobeNewswire, Inc.
… (Nasdaq: RLMD), a clinical-stage biotechnology company focused on developing transformative …
-
Arvinas Announces Retirement of Chief Executive Officer and Succession Plan
09 Jul 2025 11:00 GMT
GlobeNewswire, Inc.
… . (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a … : ARVN) is a clinical-stage biotechnology company dedicated to improving the …
-
BioCryst to Highlight Patient-focused Research at the 2025 US HAEA National Summit
09 Jul 2025 11:00 GMT
GlobeNewswire, Inc.
… BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment …
-
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock
09 Jul 2025 01:36 GMT
GlobeNewswire, Inc.
… Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision … , Inc. Cogent Biosciences is a biotechnology company focused on developing precision …
-
Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock
08 Jul 2025 20:26 GMT
GlobeNewswire, Inc.
… Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision … , Inc. Cogent Biosciences is a biotechnology company focused on developing precision …
